BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 1362212)

  • 1. The effect of withdrawal of dopaminergic medication on simple and choice reaction time and the use of advance information in Parkinson's disease.
    Jahanshahi M; Brown RG; Marsden CD
    J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1168-76. PubMed ID: 1362212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of simple and choice reaction time in Parkinson's, Huntington's and cerebellar disease.
    Jahanshahi M; Brown RG; Marsden CD
    J Neurol Neurosurg Psychiatry; 1993 Nov; 56(11):1169-77. PubMed ID: 8229028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simple and choice reaction time and the use of advance information for motor preparation in Parkinson's disease.
    Jahanshahi M; Brown RG; Marsden CD
    Brain; 1992 Apr; 115 ( Pt 2)():539-64. PubMed ID: 1606481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive components of reaction time in Parkinson's disease.
    Jordan N; Sagar HJ; Cooper JA
    J Neurol Neurosurg Psychiatry; 1992 Aug; 55(8):658-64. PubMed ID: 1527535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Switching between abstract rules reflects disease severity but not dopaminergic status in Parkinson's disease.
    Kehagia AA; Cools R; Barker RA; Robbins TW
    Neuropsychologia; 2009 Mar; 47(4):1117-27. PubMed ID: 19166864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impairment of willed actions and use of advance information for movement preparation in schizophrenia.
    Fuller R; Jahanshahi M
    J Neurol Neurosurg Psychiatry; 1999 Apr; 66(4):502-9. PubMed ID: 10201424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic modulation of striato-frontal connectivity during motor timing in Parkinson's disease.
    Jahanshahi M; Jones CR; Zijlmans J; Katzenschlager R; Lee L; Quinn N; Frith CD; Lees AJ
    Brain; 2010 Mar; 133(Pt 3):727-45. PubMed ID: 20305278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levodopa medication improves incidental sequence learning in Parkinson's disease.
    Beigi M; Wilkinson L; Gobet F; Parton A; Jahanshahi M
    Neuropsychologia; 2016 Dec; 93(Pt A):53-60. PubMed ID: 27686948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive and motor effects of dopaminergic medication withdrawal in Parkinson's disease.
    Fern-Pollak L; Whone AL; Brooks DJ; Mehta MA
    Neuropsychologia; 2004; 42(14):1917-26. PubMed ID: 15381022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impairment of movement initiation and execution but not preparation in idiopathic dystonia.
    Jahanshahi M; Rowe J; Fuller R
    Exp Brain Res; 2001 Oct; 140(4):460-8. PubMed ID: 11685399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of aging, Parkinson's disease, and dopaminergic medication on response selection and control.
    Willemssen R; Falkenstein M; Schwarz M; Müller T; Beste C
    Neurobiol Aging; 2011 Feb; 32(2):327-35. PubMed ID: 19269061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of acute levodopa withdrawal on motor performance and dopaminergic receptor sensitivity in patients with Parkinson's disease.
    Turjanski N; Fernandez W; Lees AJ
    J Neurol Neurosurg Psychiatry; 1993 Jul; 56(7):771-5. PubMed ID: 8331352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopaminergic modulation of motor network dynamics in Parkinson's disease.
    Michely J; Volz LJ; Barbe MT; Hoffstaedter F; Viswanathan S; Timmermann L; Eickhoff SB; Fink GR; Grefkes C
    Brain; 2015 Mar; 138(Pt 3):664-78. PubMed ID: 25567321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic medication counteracts conflict adaptation in patients with Parkinson's disease.
    Duthoo W; Braem S; Houtman F; Schouppe N; Santens P; Notebaert W
    Neuropsychology; 2013 Sep; 27(5):556-61. PubMed ID: 23815093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basal ganglia, dopamine and temporal processing: performance on three timing tasks on and off medication in Parkinson's disease.
    Jones CR; Malone TJ; Dirnberger G; Edwards M; Jahanshahi M
    Brain Cogn; 2008 Oct; 68(1):30-41. PubMed ID: 18378374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson's disease duration determines effect of dopaminergic therapy on ventral striatum function.
    MacDonald AA; Monchi O; Seergobin KN; Ganjavi H; Tamjeedi R; MacDonald PA
    Mov Disord; 2013 Feb; 28(2):153-60. PubMed ID: 23165957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Greater striatal responses to medication in Parkinson׳s disease are associated with better task-switching but worse reward performance.
    Aarts E; Nusselein AA; Smittenaar P; Helmich RC; Bloem BR; Cools R
    Neuropsychologia; 2014 Sep; 62():390-7. PubMed ID: 24912070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of dopaminergic medication on basic motor performance and executive functions in Parkinson's disease.
    Michely J; Barbe MT; Hoffstaedter F; Timmermann L; Eickhoff SB; Fink GR; Grefkes C
    Neuropsychologia; 2012 Aug; 50(10):2506-14. PubMed ID: 22776611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine depletion impairs gait automaticity by altering cortico-striatal and cerebellar processing in Parkinson's disease.
    Gilat M; Bell PT; Ehgoetz Martens KA; Georgiades MJ; Hall JM; Walton CC; Lewis SJG; Shine JM
    Neuroimage; 2017 May; 152():207-220. PubMed ID: 28263926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication impairs probabilistic classification learning in Parkinson's disease.
    Jahanshahi M; Wilkinson L; Gahir H; Dharmaindra A; Lagnado DA
    Neuropsychologia; 2010 Mar; 48(4):1096-103. PubMed ID: 20006629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.